HealthcareServices

Global Human Liver Model Market Report 2026: Emerging Trends and Growth Scenarios

February 25, 2026February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the human liver model market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Human Liver Model Market in 2026, and what figure is it projected to hit by 2030?

The human liver model market has experienced substantial growth in recent years. It is projected to expand from $2.62 billion in 2025 to $2.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market is attributable to various factors, including increased drug attrition resulting from liver toxicity, the inherent limitations of traditional animal models, the growth in pharmaceutical research and development activities, the early adoption of 2d liver cell culture models, and a heightened focus on drug safety evaluation.

The human liver model market is projected to experience substantial expansion in the coming years, with its size forecast to reach $5.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. This growth can be attributed to factors such as a heightened demand for precision toxicology models, the expansion of organ-on-chip technologies, an escalating regulatory focus on reducing animal testing, increased investment in advanced in vitro research tools, and the expanded application of human-relevant models in early drug development. Significant trends anticipated during this period include the wider adoption of advanced in vitro liver models for toxicity testing, the increased deployment of liver organoids in drug discovery pipelines, a growing inclination towards human-relevant models over animal testing, the broadened utility of liver-on-a-chip applications in preclinical research, and an escalating need for predictive hepatotoxicity assessment tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp

Which Drivers Are Affecting Market Participation In The Human Liver Model Market?

The escalating number of clinical trials is projected to stimulate the growth of the human liver model market in the future. Clinical trials are research investigations performed to evaluate the safety and effectiveness of medical interventions, treatments, or drugs when applied to humans. Human liver models are deployed in these trials to mimic and investigate drug metabolism and hepatotoxicity, which is essential for pharmaceutical development. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the overall count of clinical trials initiated within the UK climbed from 411 in 2022 to 426 in 2023. Thus, the expansion of clinical trials is serving as a significant impetus for the human liver model market.

What Segment Classifications Make Up The Human Liver Model Market?

The human liver model market covered in this report is segmented –

1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, 3D Bioprinting

2) By Application: Educational, Drug Discovery, Other Applications

3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Liver Organoids: Primary Liver Organoids, Induced Pluripotent Stem Cell (iPSC)-Derived Organoids

2) By Liver-On-A-Chip: Microfluidic Liver Chips, Multi-Organ Chip Systems

3) By 2D Models: Liver Cell Cultures, Liver Cell Lines

4) By 3D Bioprinting: Bioprinted Liver Tissues, Hybrid Bioprinted Models

How Are New Market Trends Shaping The Landscape Of The Human Liver Model Market?

Leading companies in the human liver model market are prioritizing the development of advanced solutions, such as single-organ higher throughput (HT) systems, to boost the adoption of predictive human liver models and achieve a competitive edge. A single-organ higher throughput (HT) system is a technology designed for efficient and affordable drug discovery, helping to overcome barriers in the integration of predictive human liver models. As an illustration, in February 2023, CN Bio, a UK-based organ-on-a-chip company, launched PhysioMimix with Liver-48 plate. This particular single-organ higher throughput (HT) system was created to address challenges that hinder the application of predictive human liver models in drug discovery. This technology offers a scalable and economical solution, enabling researchers to perform larger-scale comparative investigations into drug disposition, efficacy, or safety. The Liver-48 plate is a multi-chip consumable that scales down the company’s human liver model for various uses, including predicting drug-induced liver injury and assessing drug metabolism.

Which Major Firms Are Strengthening Their Position In The Human Liver Model Market?

Major companies operating in the human liver model market are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Human Liver Model Market?

North America was the largest region in the human liver model market in 2025. The regions covered in the human liver model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Human Liver Model Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12244&type=smp

Browse Through More Reports Similar to the Global Human Liver Model Market 2026, By The Business Research Company

Liver Diseases Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rat Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Anatomical Models Market Report 2026

https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795